Competitors Scramble to Catch Up with Novartis in Radiopharmaceuticals Industry

Drug developers are optimistic about the potential of delivering radiation directly to tumors as a groundbreaking advancement in cancer treatment. Pharmaceutical giants like Bristol Myers Squibb, AstraZeneca, and Eli Lilly

Detail